Proactive anti-inflammatory therapy in the advanced stages of a new coronavirus infection. Main results of the inpatient phase of the COLORIT study (Colchicin vs. Ruxolitinib and secukinumab in an open, prospective, randomized trial in patients with novel coronavirus infection COVID-19)
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Proactive anti-inflammatory therapy in the advanced stages of a new coronavirus infection. Main results of the inpatient phase of the COLORIT study (Colchicin vs. Ruxolitinib and secukinumab in an open, prospective, randomized trial in patients with novel coronavirus infection COVID-19)
Authors
Keywords
-
Journal
KARDIOLOGIYA
Volume 62, Issue 12, Pages 11-22
Publisher
APO Society of Specialists in Heart Failure
Online
2023-01-13
DOI
10.18087/cardio.2022.12.n2316
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19
- (2022) Jennifer Hammond et al. NEW ENGLAND JOURNAL OF MEDICINE
- Blockade of interleukin seventeen (IL-17A) with secukinumab in hospitalized COVID-19 patients – the BISHOP study
- (2022) Gustavo Gomes Resende et al. Infectious Diseases
- Levilimab and baricitinib prescribing experience in outpatient COVID-19 patients’ treatment
- (2022) Alexey I. Khripun et al. TERAPEVTICHESKII ARKHIV
- Tocilizumab, netakimab, and baricitinib in patients with mild-to-moderate COVID-19: An observational study
- (2022) Ekaterina A. Bryushkova et al. PLoS One
- How evaluate results of treatment in patients with COVID-19? Symptomatic Hospital and Outpatient Clinical Scale for COVID-19 (SHOCS-COVID)
- (2021) V. Yu. Mareev et al. KARDIOLOGIYA
- Silencing of SARS‐CoV‐2 with modified siRNA‐peptide dendrimer formulation
- (2021) Musa Khaitov et al. ALLERGY
- Proactive anti-inflammatory therapy with colchicine in the treatment of advanced stages of new coronavirus infection. The first results of the COLORIT study
- (2021) V. Yu. Mareev et al. KARDIOLOGIYA
- Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19
- (2021) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Anti-IL-17 monoclonal antibodies in hospitalized patients with severe COVID-19: A pilot study
- (2021) Sergey N. Avdeev et al. CYTOKINE
- Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients
- (2021) Angélica Jayk Bernal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Colchicine use in patients with COVID-19: A systematic review and meta-analysis
- (2021) Leonard Chiu et al. PLoS One
- Novel coronavirus infection during the 2019–2020 epidemic: preparing intensive care units—the experience in Sichuan Province, China
- (2020) Xuelian Liao et al. INTENSIVE CARE MEDICINE
- Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial
- (2020) Yang Cao et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Potential role of IL‐17 blocking agents in the treatment of severe COVID‐19?
- (2020) Vedrana Bulat et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Steroid pulse -therapy in patients With coronAvirus Pneumonia (COVID-19), sYstemic inFlammation And Risk of vEnous thRombosis and thromboembolism (WAYFARER Study)
- (2020) V. Yu. Mareev et al. KARDIOLOGIYA
- Author’s response to Letter
- (2020) John FitzGerald et al. ARTHRITIS CARE & RESEARCH
- Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19
- (2020) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Mechanisms Underlying the Anti-inflammatory and Immunosuppressive Activity of Ruxolitinib
- (2019) Elena Maria Elli et al. Frontiers in Oncology
- The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation
- (2018) Gonzalo J. Martínez et al. ATHEROSCLEROSIS
- IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis
- (2012) James G. Krueger et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- An Overview of Tubulin Inhibitors That Interact with the Colchicine Binding Site
- (2012) Yan Lu et al. PHARMACEUTICAL RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now